公司概覽
業務類別 Drug Manufacturers - Specialty & Generic
業務概覽 Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up one-third of Viatris' total sales. The remaining sales are derived from its portfolio of legacy products, including Lipitor, Norvasc, Lyrica, and Viagra.
公司地址 1000 Mylan Boulevard, Canonsburg, PA, USA, 15317
電話號碼 +1 724 514-1800
傳真號碼 --
公司網頁 https://www.viatris.com
員工數量 30000
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Scott A. Smith Director and Chief Executive Officer 美元 1.45M 02/04/2026
Mr. Matthew J. Maletta Chief Legal Officer -- 03/02/2026
Mr. Paul B. Campbell Interim Chief Financial Officer, Chief Accounting Officer and and Corporate Controller -- 04/05/2026
Dr. Corinne Le Goff, Pharm.D. Chief Commercial Officer 美元 899.33K 02/04/2026
Mr. Andrew Enrietti Chief Administrative and Transformation Officer 美元 684.90K 02/04/2026
Mr. Matthew Maletta Chief Legal Officer -- 02/04/2026
 
董事會成員
董事會 職務 更新日期
Ms. Elisha W. Finney Independent Director 02/04/2026
Mr. James M. Kilts Independent Director 02/04/2026
Mr. Wyllie Don Cornwell Independent Director 02/04/2026
Mr. Mark W. Parrish Vice Chairman of the Board 02/04/2026
Mr. Scott A. Smith Director and Chief Executive Officer 02/04/2026
Ms. Melina E. Higgins Chairman of the Board 02/04/2026
Mr. David S. Simmons Independent Director 02/04/2026
Ms. JoEllen Lyons Dillon Independent Director 02/04/2026
Dr. Michael Severino, M.D. Independent Director 02/04/2026
Dr. Rogerio Vivaldi Coelho, M.B.A.,M.D. Independent Director 02/04/2026
Mr. Richard A. Mark, C.P.A. Independent Director 02/04/2026
Mr. Leo Groothuis Independent Director 02/04/2026
Mr. Frank D’Amelio Independent Director 02/04/2026
 
所屬ETF (更新日期: 14/11/2026 02:19)
代號 名稱 佔比% ▼ 持有日期
XRMIGlobal X S&P 500® Risk Managed Inc ETF0.0001%30/10/2026
JPFPJPMorgan Managed Futures Plus ETF0.0001%30/10/2026
PHDGInvesco S&P 500® Downside Hedged ETF0.0001%30/10/2026
HAWGHCM Hedged Equity ETF0.0001%30/10/2026
SPYHNEOS S&P 500 Hedged Equity Income ETF0.0001%30/10/2026
RECIColumbia Research Enhanced Cor PrmIncETF0.0001%31/10/2026
TOPCiShares S&P 500 3% Capped ETF0.0001%30/10/2026
SPXDXtrackers S&P 500 Divers Sect Weight ETF0.00005%29/10/2026
PWSPacer WealthShield ETF0.00005%30/10/2026
HRSKToews Agility Shares Hedged Risk ETF0.00004%30/10/2026
FEACFidelity Enhanced U.S. All-Cap Eq ETF0.00003%30/10/2026
GTPEGoldman Sachs MSCI Wld Priv Eq RtTrkrETF0.00002%30/10/2026
BBBCYBER HORNET S&P500 Bitcoin 75/25StgyETF0.00001%30/10/2026
TRUHVaneck Healthcare TruSector ETF0.00001%31/10/2026
XTRGlobal X S&P 500® Tail Risk ETF0.00001%30/10/2026
FBProshares S&P 500 Dynamic Buffer ETF0.000003%31/08/2026
XXSPSubversive S&P 500 Redacted ETF0.000003%30/10/2026
AIEDDefiance LLM Catalyst Momentum ETF<0.000001%03/09/2026
DEWWisdomTree Global High Dividend ETF<0.000001%28/10/2026
DFASDimensional US Small Cap ETF<0.000001%14/09/2026
  1    2    3    4    5    6    7    8    9    10    11    12   13    14  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.